NO133400B - - Google Patents

Download PDF

Info

Publication number
NO133400B
NO133400B NO925/71A NO92571A NO133400B NO 133400 B NO133400 B NO 133400B NO 925/71 A NO925/71 A NO 925/71A NO 92571 A NO92571 A NO 92571A NO 133400 B NO133400 B NO 133400B
Authority
NO
Norway
Prior art keywords
compound
salt
salts
effect
acid addition
Prior art date
Application number
NO925/71A
Other languages
English (en)
Norwegian (no)
Other versions
NO133400C (de
Inventor
C Jeanmart
N M Messer
P Simon
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of NO133400B publication Critical patent/NO133400B/no
Publication of NO133400C publication Critical patent/NO133400C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO925/71A 1970-03-12 1971-03-11 NO133400C (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707008932A FR2081572B1 (de) 1970-03-12 1970-03-12

Publications (2)

Publication Number Publication Date
NO133400B true NO133400B (de) 1976-01-19
NO133400C NO133400C (de) 1976-04-28

Family

ID=9052168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO925/71A NO133400C (de) 1970-03-12 1971-03-11

Country Status (18)

Country Link
US (1) US3759924A (de)
JP (1) JPS5341156B1 (de)
AT (1) AT303042B (de)
BE (1) BE764133A (de)
CA (1) CA933928A (de)
CH (1) CH521347A (de)
DE (1) DE2112026C3 (de)
DK (1) DK126000B (de)
ES (1) ES389180A1 (de)
FI (1) FI49034C (de)
FR (1) FR2081572B1 (de)
GB (1) GB1285016A (de)
IE (1) IE35209B1 (de)
IL (1) IL36398A (de)
NL (1) NL7102897A (de)
NO (1) NO133400C (de)
SE (1) SE360655B (de)
ZA (1) ZA711602B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109470U (de) * 1984-12-20 1986-07-11
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6291425B1 (en) * 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
WO1999011622A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6545011B2 (en) 2000-07-13 2003-04-08 Guilford Pharmaceuticals Inc. Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227085A (en) * 1963-09-05 1966-01-04 James L Ramer Shot shell
DE1670694B2 (de) * 1966-05-05 1976-07-22 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von tetrahydroisochinolinen
FR1583755A (de) * 1968-03-06 1969-12-05
FR2028672A6 (de) * 1968-03-06 1970-10-16 Rhone Poulenc Sa
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines

Also Published As

Publication number Publication date
DE2112026C3 (de) 1979-10-25
IL36398A (en) 1973-10-25
IL36398A0 (en) 1971-05-26
SE360655B (de) 1973-10-01
IE35209B1 (en) 1975-12-10
IE35209L (en) 1971-09-12
DK126000B (da) 1973-05-28
CA933928A (en) 1973-09-18
US3759924A (en) 1973-09-18
BE764133A (fr) 1971-09-13
JPS5341156B1 (de) 1978-10-31
NL7102897A (de) 1971-09-14
CH521347A (fr) 1972-04-15
AT303042B (de) 1972-11-10
ZA711602B (en) 1971-11-24
ES389180A1 (es) 1973-06-01
FR2081572B1 (de) 1973-04-06
FR2081572A1 (de) 1971-12-10
FI49034B (de) 1974-12-02
GB1285016A (en) 1972-08-09
DE2112026A1 (de) 1971-09-23
FI49034C (fi) 1975-03-10
DE2112026B2 (de) 1979-03-08
NO133400C (de) 1976-04-28

Similar Documents

Publication Publication Date Title
NO133400B (de)
CZ286325B6 (cs) Amidy kyseliny indazolylkarboxylové, farmaceutické prostředky s obsahem těchto látek
CA1329203C (en) Esters of hexahydro-8-hydroxy-2, 6-methano-2h- quinolizin-3(4h)-one and related compounds
US3968243A (en) Substituted guanidine compounds in the treating of arrythmias
EP3828169A1 (de) Dikationsverbindung, herstellungsverfahren dafür und verwendung davon
NO140348B (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser
KR100352899B1 (ko) 새로운3-페닐설포닐-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제
NO125675B (de)
NO135983B (de)
US3828050A (en) 3-alkoxy-14-acyloxydihydromorphinone derivatives
EP0180158A1 (de) Eine Thiazinverbindung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
JPH0543576A (ja) 20,21−ジノルエブルナメニンの新規の誘導体、それらの製造方法及び得られる新規の中間体、それらの薬剤としての使用並びにそれらを含有する組成物
JPH0352465B2 (de)
US3426017A (en) Sulfonylurea compounds
JP2676113B2 (ja) 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤
US4002753A (en) 6-Substituted 3-carbethoxyhydrazinopyridazines
JPS60116678A (ja) n‐プロパノールアミン誘導体エーテル
NO154088B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
US2734062A (en) Method of making them
US2985653A (en) New piperazinyl-alkyl-phenthiazines and their preparation
US4558052A (en) 10-Bromosandwicine, 10-bromoisosandwicine, pharmaceutical compositions thereof, and methods of treating heart rhythm disorders with them
EP0011854B1 (de) 4-(2'-Pyridylamino)phenylessigsäure-Derivate, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Mittel und ihre Verwendung
US3748333A (en) Palladium hydrogenation process for 3,4 dihydroisoquinalines
US3015658A (en) Process for the preparation of new
Bamford et al. The neuromuscular blocking activity of some monoquaternary androstane derivatives